Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer
1997

Platelet-derived endothelial cell growth factor and lung cancer

Sample size: 107 publication Evidence: moderate

Author Information

Author(s): Ml Koukourakis, A Giatromanolaki, KJ O'Byrne, M Comley, RM Whitehouse, DC Talbot, KC Gatter, AL Harris

Primary Institution: Imperial Cancer Research Fund Medical Oncology Unit; Department of Radiotherapy and Oncology, University Hospital of Iraklion; Department of Cellular Science, Oxford Radcliffe Hospital

Hypothesis

Does PD-ECGF/TP expression correlate with tumor angiogenesis and prognosis in non-small-cell lung cancer?

Conclusion

High expression of PD-ECGF/TP in non-small-cell lung cancer cells is associated with a more aggressive tumor phenotype and poorer prognosis, particularly in node-negative cases.

Supporting Evidence

  • 25% of cases showed high PD-ECGF/TP expression associated with high vascular grade.
  • 44% of high vascular grade tumors had positive PD-ECGF/TP reactivity.
  • Positive PD-ECGF/TP expression was more frequent in T2-staged cases.

Takeaway

This study found that a protein called PD-ECGF/TP is linked to how blood vessels grow in lung cancer, which can affect how serious the cancer is.

Methodology

Immunohistochemical evaluation of PD-ECGF/TP expression in surgically resected specimens from 107 patients with operable non-small-cell lung cancer.

Limitations

The study did not find a significant correlation between PD-ECGF/TP expression and overall survival in all patients.

Participant Demographics

107 patients with operable non-small-cell lung cancer, including 65% squamous cell carcinomas and 35% adenocarcinomas.

Statistical Information

P-Value

0.04

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication